Biosimilar Manufacturing

Biosimilar Manufacturing is the biopharmaceutical production process that involves the development and synthesis of highly similar versions of approved biological reference products through recombinant DNA technology, cell culture, and rigorous analytical characterization to ensure comparable quality, safety, and efficacy.

50

Publications

1.8K

Citations

276

Authors

161

Institutions

Publications per year

2017–2026

15

Authors

276

  1. AS
    Anurag S. Rathore

    Indian Institute of Technology Delhi, India

    3 publications · 85 citations

    3

    h-index

  2. JG
    João Gonçalves

    University of Lisbon, Portugal

    2 publications · 55 citations

    2

    h-index

  3. SC
    Shein‐Chung Chow

    Duke University, United States

    2 publications · 54 citations

    2

    h-index

  4. JE
    João Eurico Fonseca

    University of Lisbon, Portugal

    2 publications · 55 citations

    2

    h-index

  5. FA
    Filipe Araújo

    University of Lisbon, Portugal

    2 publications · 55 citations

    2

    h-index

1–5 of 276

Venues

  1. PubMed

    Repository · 7 publications · 342 citations

    7

    h-index

  2. BioDrugs

    4 publications · 160 citations

    4

    h-index

  3. Frontiers in Pharmacology

    2 publications · 130 citations

    2

    h-index

  4. Reumatología Clínica (English Edition)

    2 publications · 28 citations

    2

    h-index

  5. mAbs

    2 publications · 119 citations

    2

    h-index

1–5